Extract
Acute pulmonary embolism is one of the main causes of death, morbidity and hospitalisation [1, 2]. The most common cause of early death in these patients is right ventricular failure [1–3]. Complete resolution of the pulmonary thrombus at 6 months of evolution is not achieved in 57% of patients, with persistent right ventricular dysfunction (RVD) in 6–8% of patients and persistent pulmonary arterial hypertension (PAH) in 7–13.5% of patients who received treatment with heparin or fibrinolytic agents [4–8]. Percutaneous mechanical thrombectomy (PMT) is accepted as a treatment in patients with high-risk acute pulmonary embolism with contraindications to systemic thrombolysis or when the treatment has failed [1, 2, 9].
Abstract
Percutaneous mechanical thrombectomy in acute PE restores right ventricle function in most patients at 40 months http://ow.ly/lhTh304sqeY
Footnotes
Conflict of interest: None declared.
- Received March 22, 2016.
- Accepted September 11, 2016.
- Copyright ©ERS 2017